MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease

E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz (Ordu, Turkey)

Meeting: 2017 International Congress

Abstract Number: 123

Keywords: Urogenital dysfunction

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To investigate the relationship between urinary dysfunction (UD) and anxiety and depression in Parkinson’s Disease (PD).   

Background: Urinary dysfunction is one of the most frequent non-motor symptoms in PD. Neuropsychiatric problems are observed in two third of the patients, most of which have been reported as depression and anxiety. It has been considered that the urological problems appearing in PD may form a basis for the development of anxiety and depression.

Methods: The study included 48 patients with a diagnosis of idiopathic PD. The Hamilton depression and Hamilton anxiety scales were applied to all patients. The urological complaints were recorded individually and the urinary complaints were questioned using the IPSS (the International Prostate Symptom Score) survey. 

Results: Among the participants, 32 were male and 16 were female. The mean age was 69.84 years.  The UD and the anxiety and depression scores were related (p=0.01 and p=0.01, respectively). Urinary complaints had increased the risk of depression and anxiety by 1.06 and 1.28 -fold, respectively. Urgency was found to be related to anxiety and depression scores (p=0.04, p=0.04). Urgency had increased the anxiety and depression scores by 1.05 and 1.07-fold, respectively. Nocturia was found to be related to anxiety (p<0.001).It was not related to depression (p=0.42). Nocturia had increased anxiety scores by 1.19- fold and incontinence had increased the risk of anxiety by 1.24-fold. There was a relationship between incontinence and anxiety (p=0.02), no relation was determined between incontinence and depression (p=0.84). A relationship was determined between IPSS score and depression and anxiety (p=0.03, p=0.005). The IPSS score had increased depression and anxiety risks by 1.1-fold. 

Conclusions: In our study, nocturia and incontinence were related to the development of anxiety in particular, and was not related to the development of depression. Additionally, the total score of IPSS, which investigated the lower urinary system complaints (incomplete emptying, urination, urgency, weak flow, nocturia frequency, straining frequency) was related to both depression and anxiety.  In conclusion, the presence of urinary symptoms alone has increased the incidence of anxiety by a minimum of 1-fold, whereas the increase in the frequency of urinary symptoms has increased the risk of both anxiety and depression in PD.

 

To cite this abstract in AMA style:

E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz. Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/effect-of-urinary-dysfunction-on-depression-and-anxiety-development-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effect-of-urinary-dysfunction-on-depression-and-anxiety-development-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley